These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 38598478)

  • 1. Intense FDG Uptake in Well-Differentiated Inflammatory Liposarcoma of the Retroperitoneum.
    Zhao Q; Dong A; Zuo C; Fang Y
    Clin Nucl Med; 2024 Jul; 49(7):685-687. PubMed ID: 38598478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Histologic Subtype and FNCLCC Grade by SUVmax Measured on
    Li CP; Liu DN; Zhou NN; Tian XY; Wang Z; Liu BN; Hao CY
    Contrast Media Mol Imaging; 2021; 2021():7191363. PubMed ID: 33505228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Round cell liposarcoma presenting as an FDG-positive primary with an FDG-negative retroperitoneal metastasis: a pitfall for F-18 FDG PET/CT imaging.
    Rakheja R; Makis W; Nahal A; Alabed YZ; Abikhzer G; Probst S; Hickeson M
    Clin Nucl Med; 2011 Dec; 36(12):e213-6. PubMed ID: 22064114
    [No Abstract]   [Full Text] [Related]  

  • 4. Accurate grading of 3 synchronous liposarcomas assessed by PET-CT in a single patient.
    Reddy MP; Sangster GP; Takalkar AM; Heldmann M; Zhang RD; Lilien DL
    Clin Nucl Med; 2007 Dec; 32(12):937-9. PubMed ID: 18030046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maximum standardized uptake value on
    Rhu J; Hyun SH; Lee KH; Jo SJ; Lee KW; Park JB; Kim SJ
    Sci Rep; 2019 Apr; 9(1):6605. PubMed ID: 31036901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 18F-FDG PET/CT Imaging of Adrenal Liposarcoma.
    Wang R; Fan Q; Tian R
    Clin Nucl Med; 2020 Jul; 45(7):570-571. PubMed ID: 32453082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Retroperitoneal well-differentiated inflammatory liposarcoma].
    Driss M; Bacha D; Mrad K; Dhouib R; Sassi S; Abbes I; Chebbi A; Romdhane KB
    Ann Pathol; 2007 Feb; 27(1):35-7. PubMed ID: 17568358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A case of large retroperitoneal lipoma mimicking liposarcoma].
    Lee KR; Seo TJ; Cho JH; Kim HI; Hur YH; Cho SB; Lee WS; Joo YE
    Korean J Gastroenterol; 2010 Jun; 55(6):394-8. PubMed ID: 20571308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FDG PET/CT Findings of a Primary Paravertebral Liposarcoma.
    Wang R; Shen G; Tian R
    Clin Nucl Med; 2022 Jan; 47(1):70-72. PubMed ID: 34034329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Extrarenal Retroperitoneal Angiomyolipoma Masquerading as Retroperitoneal Liposarcoma : A Report of Two Cases].
    Yamamoto R; Inoue T; Numakura K; Tsuruta H; Maeno A; Saito M; Narita S; Tsuchiya N; Satoh S; Habuchi T
    Hinyokika Kiyo; 2016 Jun; 62(6):317-22. PubMed ID: 27452495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The role of
    Subramaniam S; Callahan J; Bressel M; Hofman MS; Mitchell C; Hendry S; Vissers FL; Van der Hiel B; Patel D; Van Houdt WJ; Tseng WW; Gyorki DE
    J Surg Oncol; 2021 Mar; 123(4):1081-1087. PubMed ID: 33444466
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET evaluation of fatty tumors in the extremity: possibility of using the standardized uptake value (SUV) to differentiate benign tumors from liposarcoma.
    Suzuki R; Watanabe H; Yanagawa T; Sato J; Shinozaki T; Suzuki H; Endo K; Takagishi K
    Ann Nucl Med; 2005 Dec; 19(8):661-70. PubMed ID: 16444991
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PSMA and FDG PET/CT Findings in Patient With Dedifferentiated Liposarcoma and Prostate Cancer Metastases.
    Liao X; Sun H; Chen X; Fan Y; Zhang J
    Clin Nucl Med; 2024 Jul; 49(7):652-654. PubMed ID: 38689438
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-FDG PET/CT Imaging of G-CSF-Producing Dedifferentiated Liposarcoma.
    Eizuru Y; Nakajo M; Nakajo M; Shinohara N; Yoshiura T
    Clin Nucl Med; 2022 Jan; 47(1):e98-e100. PubMed ID: 34183499
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Well-differentiated liposarcoma with low-grade osteosarcomatous component: an underrecognized variant.
    Yoshida A; Ushiku T; Motoi T; Shibata T; Fukayama M; Tsuda H
    Am J Surg Pathol; 2010 Sep; 34(9):1361-6. PubMed ID: 20697254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The role of 18F-fluorodeoxyglucose (FDG)-positron emission tomography/computed tomography (PET/CT) in liposarcoma of the chest wall].
    Yamamoto H; Sugimoto S; Miyoshi K; Yamamoto H; Soh J; Yamane M; Toyooka S; Oto T; Miyoshi S
    Kyobu Geka; 2014 Jan; 67(1):4-8. PubMed ID: 24743405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of soft tissue lesions suspicious for liposarcoma by F18-deoxyglucose (FDG) positron emission tomography (PET).
    Schwarzbach MH; Dimitrakopoulou-Strauss A; Mechtersheimer G; Hinz U; Willeke F; Cardona S; Attigah N; Strauss LG; Herfarth C; Lehnert T
    Anticancer Res; 2001; 21(5):3609-14. PubMed ID: 11848531
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MRI, enhanced CT, and FDG PET/CT in primary retroperitoneal mucinous cystadenocarcinoma.
    Dong A; Zhai Z; Wang Y; Zuo C
    Clin Nucl Med; 2015 Jan; 40(1):50-3. PubMed ID: 24445275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retroperitoneal liposarcoma with various histological figures].
    Tomonaga T; Okuyama K; Nagao K; Tabata Y; Enomoto K; Koh Z; Hiura T; Sato H; Isono K
    Gan No Rinsho; 1986 Jul; 32(8):927-32. PubMed ID: 3747152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol 18F-FDG PET/CT: A Noninvasive Approach for Differential Diagnosis of Hibernoma and Liposarcoma.
    Ciappuccini R; Bardet S; Aide N
    Clin Nucl Med; 2017 Nov; 42(11):879-880. PubMed ID: 28902737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.